Orkla Q2 profit triples on hydropower sale; core growth remains modest

Orkla ASA reported a significant increase in Q2 2025 profit to NOK 6.37 billion, primarily driven by a NOK 4.8 billion gain from the divestment of its hydropower assets. While adjusted EBIT rose 6% and operating revenue increased 5%, underlying segment performance was mixed, with some divisions declining. The period also saw a decrease in cash flow from operations, contributing to an increase in net interest-bearing debt and a decline in the equity ratio.

Analysis

Orkla ASA's second-quarter 2025 results present a complex picture, where a headline profit of NOK 6.37 billion is heavily skewed by a one-time NOK 4.8 billion gain from the divestment of its hydropower assets. A more accurate reflection of operational performance is the modest 6% increase in adjusted EBIT to NOK 1.87 billion on a 5% revenue rise, with adjusted diluted EPS inching up to NOK 1.56 from NOK 1.55. The company's ongoing portfolio restructuring is evident, but underlying business health is inconsistent. Strong EBIT growth in segments like Food Ingredients (+20%) and Home & Personal Care (+13%) was counteracted by significant declines in Health (-21.2%) and House Care (-28%), indicating uneven execution across the portfolio. Furthermore, the company's financial position has weakened; cash flow from operations for the first half declined to NOK 2.45 billion from NOK 2.85 billion a year prior, while substantial capital returns via dividends and buybacks contributed to an increase in net interest-bearing debt to NOK 19.8 billion and a drop in the equity ratio to 54.2%.

Key Decisions for Investors

• Investors should look past the headline profit figure, which is inflated by a one-off asset sale, and instead focus on the modest underlying adjusted EBIT growth and mixed segment performance.
• The deteriorating cash flow and rising net debt, coupled with aggressive capital returns, warrant close scrutiny of the balance sheet's sustainability.
• Given the significant divergence in segmental performance, it is critical to monitor for improvement in underperforming divisions like Health and House Care, as their weakness offsets gains elsewhere.
• The success of the ongoing strategic M&A activity is a key long-term variable; investors should assess whether the divestment of stable assets and reinvestment into core areas will ultimately enhance consistent profitability.